Form 4 · Filed Jul 7, 2026, 09:11 PM UTC
XERS/Xeris Biopharma Holdings, Inc.
Pieper Steven — See Remarks
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | S | sell | 27,600 | $9 | $235,276 | 1,366,053 |
| Jul 6, 2026 | S | sell | 17,400 | $9 | $147,900 | 1,393,653 |
Source: SEC EDGAR raw filing ↗ · Accession 0001875714-26-000007